華資實業(600191.SH):控股股東籌劃重大事項 4月15日起停牌
格隆匯4月14日丨華資實業(600191.SH)公佈,公司於2025年4月14日收到公司控股股東盛泰創發的通知,獲悉盛泰創發正在籌劃引入戰略投資者增加註冊資本,該事項可能導致公司實控人變更。鑑於上述事項正在洽談當中,尚存在不確定性,爲保證信息披露公平,維護投資者利益,避免造成公司股價異常波動,根據《上海證券交易所股票上市規則》《上海證券交易所上市公司自律監管指引第4號—停復牌》等有關規定,經公司申請,公司股票(將於2025年4月15日(星期二)起停牌。預計停牌時間不超過2個交易日。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.